Hindustan Syringes to partner WHO for auto-disable syringes
Hindustan Syringes and Medical Device (HBD) will partner the World Health Organization (WHO) in a campaign to prevent deaths and serious infections caused due to reusable syringes and unsafe injection practices.
New Delhi: Hindustan Syringes and Medical Device (HBD) will partner the World Health Organization (WHO) in a campaign to prevent deaths and serious infections caused due to reusable syringes and unsafe injection practices.
The WHO campaign aims to completely eliminate the practice of using re-usable syringes and replace it with auto-disable (AD) syringes.
"Hindustan Syringes and Medical Devices shall partner with WHO and play a very crucial role in this third global health initiative to help prevent millions of deaths and serious infections," the company said in a statement.
The campaign, which would be formally launched shortly, will focus on broad-basing the use of auto disposal syringes from immunisation to therapeutic usage, it added.
"This by-far is the biggest of WHO's global initiative since the remarkable success of polio eradication and hand-wash awareness campaigns," the company said.
As per WHO, the use of auto disable (AD) syringes could deliver a net savings to USD 850 million worldwide from reduced treatment cost of HIV, hepatitis B and C.
The campaign would benefit Hindustan Syringes and Medical Devices Ltd (HMD) as it is the world's largest manufacturer of AD syringes.
"Syringes should be a life giver, not life taker. It is a very fulfilling moment for my company and an emotional one at personal level as thousands of people unnecessarily lose life in our country due to unsafe injection practices," said HMD Joint Managing Director Rajiv Nath.